Currently, TRIM35 has been found to act as a tumor-promoting gene in hepatocellular carcinoma and erythroleukemic, and it could regulate erythroid differentiation by modulating GATA-1 activity [20–22]. The gene discussed is TRIM35; the disease is neoplasm.